The newly generated MLL-AF9 cells (MLL-AF9-2021) produced AML more quickly in Rag2−/− mice than WT mice (Fig. 6b), indicating that they are susceptible to adaptive immunity. This evidence concerns the gene KMT2A and acute myeloid leukemia.